gliclazide has been researched along with Acute Confusional Senile Dementia in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-García, A | 1 |
| Rojas, S | 1 |
| Rivas-García, L | 1 |
| Navarro-Hortal, MD | 1 |
| Romero-Márquez, JM | 1 |
| Fernández-Bolaños, JG | 1 |
| Choquesillo-Lazarte, D | 1 |
| Salinas-Castillo, A | 1 |
| López, Ó | 1 |
| Quiles, JL | 1 |
| Rodríguez-Diéguez, A | 1 |
1 other study available for gliclazide and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
A gliclazide complex based on palladium towards Alzheimer's disease: promising protective activity against Aβ-induced toxicity in
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Caenorhabditis elegans; Co | 2022 |